# The Human Medicines Regulations 2012, Regulation 204: Obligation on licensing authority in relation to public announcements


(1) This regulation applies where the licensing authority intends to make a public announcement relating to information on pharmacovigilance concerns which relate to products authorised under a UKMA(NI) or UKMA(UK)(Category 2).
(2) Subject to paragraph (4), the licensing authority must inform the bodies specified in paragraph (3) not less than 24 hours prior to making the public announcement.
(3) The bodies specified in this paragraph are—
(a) the EMA;
(b) the European Commission; and
(c) the competent authority of each EEA State other than the United Kingdom.
(4) Paragraph (2) does not apply if the information in the announcement needs to be made public urgently for the protection of public health.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/regulation/204 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/regulation-204
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.